News & Updates

Show Multimedia Only
Glycaemic control not a risk factor for cerebral small vessel disease in T1D

Glycaemic control not a risk factor for cerebral small vessel disease in T1D

16 Mar 2022

Among patients with type 1 diabetes (T1D), medium- and long-term blood glucose control and long-term glycaemic variability do not exert any influence on the risk of developing cerebral small vessel disease, a study has found.

Glycaemic control not a risk factor for cerebral small vessel disease in T1D

16 Mar 2022
Roxadustat proven safe, effective for anaemia in CKD patients

Roxadustat proven safe, effective for anaemia in CKD patients

16 Mar 2022

Treatment with roxadustat leads to significant improvements in renal anaemia among patients with chronic kidney disease (CKD) by increasing haemoglobin (Hb) level and iron metabolism, according to a recent study. However, the risk of serious adverse events (AEs) during treatment must be considered.

Roxadustat proven safe, effective for anaemia in CKD patients

16 Mar 2022